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Rating
￿￿ Of major importance.
Introduction
The incidence, associated risk factors, and clinical con-
sequences of coronary artery plaque rupture have been
previously well described [1, 2]. In contrast, similar data for
the peripheral vasculature are notably lacking. Okura et al.
investigate the prevalence of plaque rupture in the ilio-
femoral circulation by intravascular ultrasound (IVUS). The
authors examine the relationship between the presence of
plaque rupture and patient characteristics and correlate their
findings with clinical outcomes.
Aim
The authors intended to define the prevalence and clinical
characteristics of plaque rupture by IVUS in patients with
peripheral arterial disease (PAD) undergoing percutaneous
intervention of ilio-femoral atherosclerotic lesions.
Methods
The study examined 101 patients (with a total of 101
lesions: 28 common iliac, 27 external iliac, and 46
superficial femoral arteries) undergoing clinically indicated
peripheral angioplasty. All patients had hsCRP levels
measured the day prior to the procedure. Angiography
and IVUS (using instruments from three different manu-
facturers) using automated pullback at 1 mm/sec were
performed to image the entirety of each respective arterial
conduit. The contralateral vessel was not imaged. Standard
IVUS dimensions were measured, including luminal cross-
sectional area (CSA), vessel area, external elastic mem-
brane (EEM) area, and plaque burden. Plaque rupture was
defined as the presence of a cavity that communicated with
the lumen with an overlying residual fibrous cap fragment.
Clinical outcomes including death, myocardial infarction,
unplanned peripheral arterial revascularization (angioplasty
or bypass surgery), ischemic stroke, and amputation (major
or minor) were followed prospectively.
Results
Forty-two patients (42%) had evidence of plaque rupture,
with the majority of individuals having a single rupture
(26 patients). The two groups (with vs without plaque
rupture) were both similar in terms of age, ankle brachial
index, and Fontaine class. However, the patients with
plaque rupture in the ilio-femoral arteries more often
presented with a history of acute coronary syndromes
(ACS; 43% vs 17%, P=0.004). Target lesion plaque
ulceration by angiography was associated with rupture by
IVUS (P<0.0001). Target lesion EEM CSA, lumen CSA,
and plaque plus media CSA were significantly larger in
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rupture. By multivariable logistic regression analysis, both
history of ACS (χ
2=8.1, odds ratio [OR]=4.1, 95% CI=
1.55–10.80, P=0.004) and male sex (χ
2=6.1, OR=4.8,
95% CI=1.39–16.39, P=0.01) were independent clinical
correlates of plaque rupture in the ilio-femoral arteries.
During follow-up (median, 14.7 months), the incidence of
major adverse cardiac or cerebrovascular events (death,
myocardial infarction, and ischemic stroke [MACCE]) was
similar between the two groups. However, the incidence of
MACCE plus peripheral vascular events (unplanned
vascular intervention and amputation) was significantly
higher in patients with plaque rupture than in patients
without plaque rupture (46% vs 21%, P=0.008). By
multivariable Cox regression analysis, plaque rupture
(hazard ratio=2.80, 95% CI=1.23–6.37, P=0.01) and
Fontaine stage IV (hazard ratio=3.50, 95% CI=1.58–
7.71, P=0.002) were independent predictors of MACCE
plus peripheral vascular events.
Discussion
The authors examine the prevalence and clinical significance
of plaque rupture in the ileo-femoral circulation. In these
patients undergoing peripheral angioplasty, plaque rupture
was noted in 42% of patients, suggesting that this is not a rare
finding in patients with symptomatic PAD. Two key parallels
are noted in this study between peripheral plaque rupture and
data from prior coronary atheroma plaque studies [3]. First,
luminal cross-sectional area and EEM areas were larger at
the target lesion in the patients who had plaque rupture
versus those without rupture, suggesting that the process of
positive remodeling is similar in peripheral arteries as in the
coronary arteries. Second, patients who had plaque rupture
in the periphery were more likely to have had ACS,
consistent with the concept that atherosclerosis is a systemic
disease. These data linking plaque vulnerability in multiple
circulations in high-risk patients are hypothesis generating.
Although the sample size is small (101 patients/arteries), this
article represents the largest evaluation of this phenomenon.
Comments
The presence of fibrous and fibrocalcific atheromas has
been well described in the peripheral circulation [4–6].
Although less commonly reported, lipid-laden atheroscle-
rotic lesions with thin fibrous caps have also been
demonstrated. Pasterkamp et al. [7] examined the inflam-
matory characteristics of thin-capped fibroatheromas in the
femoral arteries taken at autopsy from patients who died from
non-cardiovascular causes. Even in these “low-risk” patients,
vulnerable plaques were identified in the peripheral circula-
tion.In50arteries,theauthorsdocumentedheavyormoderate
stainingformacrophages inthe caporshoulderregionin45%
of femoral artery atheromas. Furthermore, those lesions that
had evidence of plaque rupture demonstrated evidence of
macrophage staining. These results are similar to the large
body of data linking inflammation with vulnerable plaque
formation and rupture in the coronary circulation.
The clinical significance of vulnerable plaques in
peripheral arteries is unclear. In the infra-inguinal circula-
tion, plaque rupture with subsequent thrombosis has been
described; however, acute presentations of this phenome-
non are difficult to document in clinical practice [8]. The
large caliber of the peripheral vessels, the presence of
collateral channels, and the chronic nature of this disease
make any acute thrombotic event difficult to ascribe to a
defined plaque rupture leading to arterial occlusion.
Repeated plaque ruptures and intra-atheroma hemorrhage,
however, are important in the pathophysiology of coronary
atheroma growth, and one might hypothesize that similar
events could lead to lesion progression in the periphery [9].
The importance of vulnerable/ruptured plaques in the
femoral circulation may lie in identification of individuals
who are at high risk for cardiovascular events. Symptomatic
PAD is associated with the presence of coronary artery
disease and generally portends a very poor prognosis.
Furthermore, peripheral plaques that demonstrate inflam-
mation or are particularly lipid rich appear to be most
associated with cardiac events [7]. The findings of Okura et
al. of increased events (MACCE and PAD events) in
patients with plaque rupture are concordant with these data.
Interestingly, the authors did not note a difference in C-
reactive protein (CRP) levels in patients with versus those
without plaque rupture, although all of these patients had
very advanced disease. While inflammation appears to play
an important role in the pathophysiology of PAD, the exact
role of specific biomarkers such as CRP remains unclear.
Elevated CRP levels have been associated with the develop-
ment and progression of PAD, with decreased future
functional capacity, and poorer response to revascularization
[10]. The precise role of CRP in modulating peripheral artery
plaque rupture remains to be further elucidated.
The use of IVUS in the coronary arteries has provided
valuable information related to arterial remodeling and
vulnerable plaque physiology [3]. In contrast, plaque
morphology and lesion vulnerability in the periphery has
been less rigorously studied. Multiple studies have de-
scribed peripheral plaque characteristics using traditional
grayscale IVUS imaging. Much like the coronary circula-
tion, such analyses are limited by the poor tissue differen-
tiation of specific plaque components. Specifically, IVUS
cannot differentiate a plaque rupture with overlying
thrombus that smoothly fills the plaque cavity and thus
188 Curr Cardiovasc Imaging Rep (2010) 3:187–189may underestimate the true incidence. Although IVUS has
excellent specificity for calcium, identification of fibrous
and fatty tissue remains challenging. In this regard,
ultrasound backscatter analysis algorithms such as the
Virtual Histology (IVUS-VH; Volcano Corporation, Rancho
Cordova, CA) technology may offer valuable information
[4]. IVUS-VH has been used to study peripheral atheroma to
variable degrees in the renal, carotid, and infrainguinal
circulation. It is interesting to note that the authors of the
present study used the 20-MHz Eagle Eye Gold (Volcano
Corporation) catheter for some of their pullbacks, which
provides VH data. While the VH data were not reported, the
plaque composition of ruptured versus nonruptured femoral
plaques remains an unsettled issue. Optical coherence
tomography provides excellent resolution and may be ideally
suited for evaluating plaque rupture in peripheral arteries.
Overall, the data presented by Okura et al. are novel and
provide an interesting look at a phenomenon that has not
been well described in the literature. The data are
hypothesis generating but highlight an area that warrants
further investigation.
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